Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $189
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice Target
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $187 to $189.
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $187 to $189.